Video Experimental Relacionado
Updated: Jul 10, 2026
09:45
Modification and Functionalization of the Guanidine Group by Tailor-made Precursors
Published on: April 27, 2017
Administración de colina: modificación de las acciones centrales de la atropina
L Wecker1, W D Dettbarn, D E Schmidt
1Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.
Science (New York, N.Y.)
|January 6, 1978
Resumen
La disponibilidad de colina influye en la forma en que el cerebro responde a los medicamentos anticolinérgicos como la atropina. La suplementación con colina antes de la atropina bloquea sus efectos sobre los niveles de acetilcolina y la absorción en el cerebro de la rata.
Área de la Ciencia:
- La neurociencia es la neurociencia.
- Farmacología Farmacología.
- La neuroquímica es la neuroquímica.
Sus antecedentes:
- Los agentes anticolinérgicos, como la atropina, impactan los sistemas de neurotransmisores en el cerebro.
- La acetilcolina es un neurotransmisor clave involucrado en las funciones cognitivas.
- La absorción de colina de alta afinidad es un paso que limita la velocidad en la síntesis de acetilcolina.
Objetivo del estudio:
- Investigar el papel de la disponibilidad de precursores de acetilcolina en la modulación de los efectos centrales de la atropina.
- Para determinar si la administración de colina puede prevenir cambios inducidos por la atropina en el metabolismo de la acetilcolina.
Principales métodos:
- A las ratas se les administró atropina, un conocido agente anticolinérgico.
- Las concentraciones de acetilcolina y la absorción de colina de alta afinidad se midieron en los tejidos corticales e hipocampales.
- La colina se administró a un grupo separado de ratas 1 hora antes de la administración de atropina.
Principales resultados:
- La atropina disminuyó significativamente las concentraciones de acetilcolina en la corteza y el hipocampo.
- La administración de atropina condujo a un aumento de la absorción de colina de alta afinidad en estas regiones del cerebro.
- La administración previa de colina impidió tanto la disminución de los niveles de acetilcolina como el aumento de la absorción de colina causada por la atropina.
Conclusiones:
- La disponibilidad de precursores de acetilcolina es un factor crítico para determinar los efectos centrales de los fármacos anticolinérgicos.
- La modulación de los niveles de colina puede ofrecer una estrategia para mitigar o prevenir las alteraciones neuroquímicas inducidas por los agentes anticolinérgicos de acción central.
- Estos hallazgos resaltan la interacción entre el suministro de precursores y la acción del fármaco en el sistema colinérgico.
Videos de Conceptos Relacionados
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
01:30Adrenergic Agonists: Therapeutic Uses
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...